Overview

The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

Status:
COMPLETED
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The trial was designed in a single dose, open, non-randomized, multi-dose parallel control group. The study of patients were mild and moderate renal insufficiency, and matched healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shenzhen Salubris Pharmaceuticals Co., Ltd.